Filing Details
- Accession Number:
- 0001415889-24-001719
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-23 21:05:19
- Reporting Period:
- 2024-01-20
- Accepted Time:
- 2024-01-23 21:05:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646649 | Jonathan Sheena | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-20 | 191 | $0.00 | 469,934 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-01-21 | 143 | $0.00 | 470,077 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-22 | 118 | $68.16 | 469,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-01-22 | 233 | $68.16 | 469,726 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2024-01-20 | 191 | $0.00 | 191 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2024-01-21 | 143 | $0.00 | 143 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,522 | No | 4 | M | Direct | ||
| 573 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 21,155 | Indirect | By Caraluna 1 Trust |
| Common Stock | 21,155 | Indirect | By Caraluna 2 Trust |
Footnotes
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
- Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
- The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter
Billionaire Hedge Funds
